Increased activity-regulating and neuroprotective efficacy of α- secretase-derived secreted amyloid precursor protein conferred by a C- terminal heparin-binding domain

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 1882-1896

  Furukawa, Katsutoshi ^a   Sopher, Bryce L ^b   Rydel, Russell E ^c   Begley, James G ^a   Pham, Dao G ^b   Martin, George M ^b   Fox, Michael ^c   Mattson, Mark P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Athena Neurosciences Inc   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Calcium homeostasis; Confocal laser scanning microscopy; Excitotoxicity; Heparinase; Potassium channels; Whole cell patch clamp

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; CALCIUM; HEPARIN; HEPARIN LYASE; POTASSIUM; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID NEUROPATHY; ARTICLE; CARBOXY TERMINAL SEQUENCE; EMBRYO; HIPPOCAMPUS; HUMAN; HUMAN CELL; NERVE CELL PLASTICITY; NEUROPROTECTION; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EUKARYOTA; PROKARYOTA;

EID: 0029841562     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67051882.x     Document Type: Article

References (84)

1. Araki W., Kitaguchi N., Tokushima Y., Ishii K., Aratake H., Shimohama S., Nakamura S., and Kimura J. (1991) Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture. Biochem. Biophys. Res. Commun. 181, 265-271.
2. Barger S. and Mattson M. P. (1995) Secreted form of the Alzheimer's amyloid precursor protein stimulates a membrane-associated guanylate cyclase. Biochem. J. 311, 45-47.
3. Barger S. W. and Mattson M. P. (1996) Secreted form of the Alzheimer's β-amyloid precursor induces neuroprotective κB-dependent transcription. Mol. Brain Res. 40, 116-126.
4. Barger S. W., Fiscus R. R., Ruth P., Hofmann F., and Mattson M. P. (1995a) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β amyloid precursor. J. Neurochem. 64, 2087-2096.
5. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92, 9328-9332.
6. Behl C., Davis J., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
7. Bendotti C., Forloni G., Morgan R., O'Hara B., Oster-Granite M., Reeves R., Gearhart J., and Coyle J. (1988) Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid, and lesioned mice. Proc. Natl. Acad. Sci. USA 85, 3628-3632.
8. Bouras C., Hof P., Giannakopoulos P., Michel J., and Morrison J. (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb. Cortex 4, 138-150.
9. Brunden K. R., Richter-Cook N. J., Chaturvedi N., and Frederickson R. C. A. (1993) pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61, 2147-2154.
10. Buee L., Ding W., Delacourte A., and Fillit H. (1993) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res. 601, 154-163.
11. Bush A., Pettingell W., de Paradis M., Tanzi R., and Wasco W. (1994) The amyloid β-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. J. Biol. Chem. 269, 26618-26621.
12. Butterfield D. A., Hensley K., Harris M., Mattson M. P., and Carney J. (1994) β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
13. Buxbaum J., Gandy S., Cicchetti P., Ehrlich M., Czernik A., Fracasso R., Ramabhadran T., Unterbeck A., and Greengard P. (1990) Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. USA 87, 6003-6006.
14. Cai X., Golde T., and Younkin S. (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259, 514-516.
15. Card J., Mead R., and Davis L. (1988) Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system. Neuron 1, 835-846.
16. Chen M. and Yankner B. A. (1991) An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types. Neurosci. Lett. 125, 223-226.
17. Cheng B. and Mattson M. P. (1991) NGF and bFGF protect rat and human central neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7, 1031-1041.
18. Citron M., OltersdorfT., Haass C., McConlogue L., Hung A., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672-674.
19. Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., and Selkoe D. J. (1994) Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymplomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. USA 91, 11993-11997.
20. Creuzet C., Loeb J., and Barbin G. (1995) Fibroblast growth factors stimulate protein tyrosine phosphorylation and mitogen-activated protein kinase activity in primary cultures of hippocampal neurons. J. Neurochem. 64, 1541-1547.
21. Esch F., Keim P., Beattie E., Blacher R., Culwell A., Oltersdorf T., McClure D., and Ward P. (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 1122-1124.
22. Felsenstein K., Hunihan L., and Roberts S. (1994) Altered cleavage and secretion of a recombinant β-APP bearing the Swedish familial Alzheimer's disease mutation. Nature Genet. 6, 251-256.
23. Ferreira A., Caceres A., and Kosik K. (1993) Intraneuronal compartments of the amyloid precursor protein. J. Neurosci. 13, 3112-3123.
24. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379, 74-78.
25. Gabuzda D., Busciglio J., Chen L. B., Matsudaira P.. and Yankner B. A. (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269, 13623-13628.
26. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz E., McConlogue S., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V7I7F β-amyloid precursor protein. Nature 373, 523-527.
27. Goodman Y. and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neural. 128, 1-12.
28. Goodman Y. and Mattson M. P. (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66, 869-872.
29. Greenberg S. M., Koo E. J., Selkoe D. J., Qiu W. Q., and Kosik K. S. (1994) Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc. Natl. Acad. Sci. USA 91, 7104-7108.
30. Grynkiewicz G., Poenie M., and Tsien R. (1985) A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
31. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., and Selkoe D. J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
32. Haass C., Hung A. Y., Selkoe D. J., and Teplow D. (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269, 17741-17748.
33. Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., and Selkoe D. J. (1995) The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nature Med. 1, 1291-1296.
34. Henriksson T., Barbour R. M., Braa S., Ward P., Fritz L. C., Johnson-Wood K., Chung H. D., Burke W., Reinikainen K. J., Riekkinen P., and Schenk D. B. (1991) Analysis and quantitation of the β-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay. J. Neurochem. 56, 1037-1042.
35. Jin L., Ninomiya H., Roch J., Schubert D., Masliah E., Otero D., and Saitoh T. (1994) Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14, 5461-5470.
36. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J., Masters C., Grzeschik K.-H., Multhaup G., Beyreuther K., and Muller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
37. Kennedy M. B. (1989) Regulation of synaptic transmission in the central nervous system: long-term potentiation. Cell 59, 777-787.
38. Klagsbrun M. and Baird A. (1991) A dual receptor system is required for bFGF activity. Cell 67, 229-231.
39. Koo E. H., Sisodia S. S., Archer D. R., Martin L. J., Weidemann A., Beyreuther K., Fischer P., Masters C. L., and Price D. L. (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. USA 87, 1561-1565.
40. Leveugle B., Scanameo A., Ding W., and Fillit H. (1994) Binding of heparin sulfate glycosaminoglycan to β-amyloid peptide: inshy; hibition by potentially therapeutic polysulfated compounds. Neuroreport 5, 1389-1392.
41. Levine E., Dreyfus C., Black I. B., and Plummer M. (1995) Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc. Natl. Acad. Sci. USA 92, 8074-8077.
42. Li L.-Y., Safran M., Aviezer D., Bohlen P., Seddon A. P., and Yayon A. (1994) Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis. Biochemistry 33, 10999-11007.
43. Lorenzo A. and Yankner B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
44. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
45. Mattson M. (1990) Second messengers in neuronal growth and degeneration, in Current Aspects of Neuroscience (Osborne N., ed), pp. 1-48. Macmillan Press, London.
46. Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25, 439-450.
47. Mattson M. P. and Furukawa K. (1996) Programmed cell life: anti-apoptotic signaling and therapeutic strategies in neurodegenerative disorders. Restor. Neurol. Neurosci. 9, 191-205.
48. Mattson M. P., Murrain M., Guthrie P. B., and Kater S. B. (1989) Fibroblast growth factor and glutamate: opposing actions in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9, 3728-3740.
49. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
50. Mattson M. P., Cheng B., Culwell A., Esch F., Lieberburg I., and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10, 243-254.
51. McGeer P., Akiyama H., Kawamata T., Yamada T., Walker D., and Ishii T. (1992) Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy. J. Neurosci. Res. 31, 428-442.
52. Mucke L., Masliah E., Johnson W. B., Ruppe M. D., Alford M., Rockenstein E. M., Forss-Petter S., Pietropaolo M., Mallory M., and Abraham C. R. (1994) Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res. 666, 151-167.
53. Mullan M. and Crawford F. (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16, 398-403.
54. Multhaup G., Bush A., Pollwein P., and Masters C. (1994) Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP). FEBS Lett. 355, 151-154.
55. Nagy Z., Esiri M., Jobst K., Morris J., King E., McDonald B., Litchfield S., Smith A., Barnetson L., and Smith A. (1995) Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 6, 21-31.
56. Narindrasorasak S., Lowery D., Gonzalez-DeWhitt P., Poorman R. A., Greenberg B., and Kisilevsky R. (1991) High affinity interaction between the Alzheimer's β-amyloid precursor proteins and the basement membrane form of heparin sulphate proteoglycan. J. Biol. Chem. 266, 12878-12883.
57. Ninomiya H., Roch J.-M., Sundsmo M., Otero D., and Saitoh T. (1993) Amino acid sequence RERMS represents the active domain of amyloid β/A4 protein precursor that promotes fibroblast growth. J. Cell Biol. 121, 879-886.
58. Ninomiya H., Roch J.-M., and Saitoh T. (1994) Secreted form of amyloid β/ A4 protein precursor (APP) binds to two distinct APP binding sites on rat B103 neuron-like cells through two different domains, but only one site is involved in neuritotropic activity. J. Neurochem. 63, 495-500.
59. Nishida E. and Gotoh Y. (1993) The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18, 128-131.
60. Nitsch R. M., Slack B. E., Wurtman R. J., and Growdon J. H. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
61. Nitsch R. M., Farber S., Growdon J. H., and Wurtman R. J. (1993) Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. USA 90, 5191-5193.
62. Oltersdorf T., Ward P., Henriksson T., Beattie E., Neve R., and Fritz L. (1990) The Alzheimer's amyloid precursor protein. J. Biol. Chem. 265, 4492-4497.
63. Palmert M., Siedlak S., Podlisny M., Greenberg B., Shelton E., Chan H., Usiak M., Selkoe D. J., Perry G., and Younkin S. (1989) Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein. Biochem. Biophys. Res. Commun. 165, 182-188.
64. Pirttila T., Kim K., Mehta P., Frey H., and Wisniewski H. (1994) Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls. J. Neurol. Sci. 127, 90-95.
65. Prehn J., Backhaub C., and Krieglstein J. (1993) Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13, 521-525.
66. Roch J.-M., Masliah E., Roch-Levecq A., Sundsmo M., Otero D. A., Veinbergs I., and Saitoh T. (1994) Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc. Natl. Acad Sci. USA 91, 7450-7454.
67. Roghani M., Mansukhani A., Dell'Era P., Bellosta P., Basilico C., Rifkin D. B., and Moscatelli D. (1994) Heparin increases the affinity of bFGF for its receptor, but is not required for binding. J. Biol. Chem. 269, 3976-3984.
68. Saitoh T., Sundsmo M., Roch J.-M., Kimura N., Cole G., Schubert D., Oltersdorf T., and Schenk D. B. (1989) Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts. Cell 58, 615-622.
69. Schlessinger J., Lax I., and Lemmon M. (1995) Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors'? Cell 83, 357-360.
70. Schubert D. and Behl C. (1993) The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res. 629, 275-282.
71. Schubert W. R., Prior A., Weidemann H., Dircksen G., Multhaup C. L., Masters C., and Beyreuther K. (1991) Localization of Alzheimer βA4 amyloid at presynaptic terminals. Brain Res. 563, 184-194.
72. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D. J., Lieberburg I., and Schenk D. (1992) Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
73. Seubert P., Oltersdorf T., Lee M., Barbour R., Blomquist C., Davis D., Bryant K., Fritz L., Galasko D., Thal L., Lieberburg l., and Schenk D. (1993) Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361, 260-263.
74. Small D., Nurcombe V., Reed G., Clarris H., Moir R., Beyreuther K., and Masters C. (1994) A heparin-binding domain in the amyloid precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J. Neurosci. 14, 2117-2127.
75. Smith D. and Johnson K. (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
76. Smith-Swintosky V. L., Pettigrew L. C., Craddock S. D., Culwell A. R., Rydel R. E., and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63, 781-784.
77. Snow A., Kinsella M., Parks E., Sekiguchi R., Miller J., Kimata K., and Wight T. (1995) Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys. 320, 84-95.
78. Sopher B., Traviss C., Cavanagh K., Jones M., and Friderici K. (1992) Purification and characterization of goat lysosomal β-mannosidase using monoclonal and polyclonal antibodies. J. Biol. Chem. 267, 6178-6182.
79. Spivak-Kroizman T., Lemmon M., Kikic I., Ladbury J., Pinchasi D., Huang J., Jaye M., Crumley G., Schlessinger J., and Lax I. (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015-1024.
80. Walker A., Turnbull J., and Gallagher J. (1994) Specific heparan sulphate saccharides mediate the activity of basic fibroblast growth factor. J. Biol. Chem. 269, 931-935.
81. Yamada T. and Kobayashi T. (1995) The mutation in amyloid precursor protein inhibits both α- and β-secretion. Neurosci. Lett. 191, 103-106.
82. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
83. Yayon A., Klagsbrun M., Esko J., Leder P., and Ornitz D. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.
84. Younkin S. (1994) The amyloid beta protein precursor mutations linked to familial Alzheimer's disease alter processing in a way that fosters amyloid deposition. Tohoku J. Exp. Med. 174, 217-223.